341 related articles for article (PubMed ID: 7501014)
1. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid.
Renaud JP; Rochel N; Ruff M; Vivat V; Chambon P; Gronemeyer H; Moras D
Nature; 1995 Dec; 378(6558):681-9. PubMed ID: 7501014
[TBL] [Abstract][Full Text] [Related]
2. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha.
Bourguet W; Ruff M; Chambon P; Gronemeyer H; Moras D
Nature; 1995 Jun; 375(6530):377-82. PubMed ID: 7760929
[TBL] [Abstract][Full Text] [Related]
4. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.
Vivat V; Zechel C; Wurtz JM; Bourguet W; Kagechika H; Umemiya H; Shudo K; Moras D; Gronemeyer H; Chambon P
EMBO J; 1997 Sep; 16(18):5697-709. PubMed ID: 9312028
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of apo-cellular retinoic acid-binding protein type II (R111M) suggests a mechanism of ligand entry.
Chen X; Tordova M; Gilliland GL; Wang L; Li Y; Yan H; Ji X
J Mol Biol; 1998 May; 278(3):641-53. PubMed ID: 9600845
[TBL] [Abstract][Full Text] [Related]
6. A structural role for hormone in the thyroid hormone receptor.
Wagner RL; Apriletti JW; McGrath ME; West BL; Baxter JD; Fletterick RJ
Nature; 1995 Dec; 378(6558):690-7. PubMed ID: 7501015
[TBL] [Abstract][Full Text] [Related]
7. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators.
Westin S; Kurokawa R; Nolte RT; Wisely GB; McInerney EM; Rose DW; Milburn MV; Rosenfeld MG; Glass CK
Nature; 1998 Sep; 395(6698):199-202. PubMed ID: 9744281
[TBL] [Abstract][Full Text] [Related]
8. The isolation and characterization of purified heterocomplexes of recombinant retinoic acid receptor and retinoid X receptor ligand binding domains.
Tian K; Norris AW; Lin CL; Li E
Biochemistry; 1997 May; 36(19):5669-76. PubMed ID: 9153406
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid receptor: a simulation analysis of retinoic acid binding and the resulting conformational changes.
Blondel A; Renaud JP; Fischer S; Moras D; Karplus M
J Mol Biol; 1999 Aug; 291(1):101-15. PubMed ID: 10438609
[TBL] [Abstract][Full Text] [Related]
10. Localization of the RAR interaction domain of cellular retinoic acid binding protein-II.
Budhu A; Gillilan R; Noy N
J Mol Biol; 2001 Jan; 305(4):939-49. PubMed ID: 11162104
[TBL] [Abstract][Full Text] [Related]
11. Purification of the human RARgamma ligand-binding domain and crystallization of its complex with all-trans retinoic acid.
Rochel N; Renaud JP; Ruff M; Vivat V; Granger F; Bonnier D; Lerouge T; Chambon P; Gronemeyer H; Moras D
Biochem Biophys Res Commun; 1997 Jan; 230(2):293-6. PubMed ID: 9016769
[TBL] [Abstract][Full Text] [Related]
12. Individual subunits of heterodimers comprised of retinoic acid and retinoid X receptors interact with their ligands independently.
Kersten S; Dawson MI; Lewis BA; Noy N
Biochemistry; 1996 Mar; 35(12):3816-24. PubMed ID: 8620004
[TBL] [Abstract][Full Text] [Related]
13. Expression of human all-trans-retinoic acid receptor beta and its ligand-binding domain in Escherichia coli.
Berggren Söderlund M; Johannesson G; Fex G
Biochem J; 1995 May; 308 ( Pt 1)(Pt 1):353-9. PubMed ID: 7755585
[TBL] [Abstract][Full Text] [Related]
14. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1.
vom Baur E; Zechel C; Heery D; Heine MJ; Garnier JM; Vivat V; Le Douarin B; Gronemeyer H; Chambon P; Losson R
EMBO J; 1996 Jan; 15(1):110-24. PubMed ID: 8598193
[TBL] [Abstract][Full Text] [Related]
15. Structural determinants of nuclear receptor assembly on DNA direct repeats.
Rastinejad F; Perlmann T; Evans RM; Sigler PB
Nature; 1995 May; 375(6528):203-11. PubMed ID: 7746322
[TBL] [Abstract][Full Text] [Related]
16. Protein and ligand adaptation in a retinoic acid binding protein.
Pattanayek R; Newcomer ME
Protein Sci; 1999 Oct; 8(10):2027-32. PubMed ID: 10548048
[TBL] [Abstract][Full Text] [Related]
17. Structure of the epididymal retinoic acid binding protein at 2.1 A resolution.
Newcomer ME
Structure; 1993 Sep; 1(1):7-18. PubMed ID: 8069623
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional models of estrogen receptor ligand binding domain complexes, based on related crystal structures and mutational and structure-activity relationship data.
Wurtz JM; Egner U; Heinrich N; Moras D; Mueller-Fahrnow A
J Med Chem; 1998 May; 41(11):1803-14. PubMed ID: 9599231
[TBL] [Abstract][Full Text] [Related]
19. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.
Muccio DD; Brouillette WJ; Alam M; Vaezi MF; Sani BP; Venepally P; Reddy L; Li E; Norris AW; Simpson-Herren L; Hill DL
J Med Chem; 1996 Sep; 39(19):3625-35. PubMed ID: 8809153
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of a novel tetrameric complex of agonist-bound ligand-binding domain of Biomphalaria glabrata retinoid X receptor.
de Groot A; de Rosny E; Juillan-Binard C; Ferrer JL; Laudet V; Pierce RJ; Pebay-Peyroula E; Fontecilla-Camps JC; Borel F
J Mol Biol; 2005 Dec; 354(4):841-53. PubMed ID: 16274693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
